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Emerging Human
Infectious Diseases:
Anthroponoses,
Zoonoses, and
Sapronoses
To the Editor: The source of infection
has always been regarded as an utmost
factor in epidemiology. Human commu-
nicable diseases can be classified accord-
ing to the source of infection as anthro-
ponoses (when the source is an infectious
human; interhuman transfer is typical),
zoonoses (the source is an infectious ani-
mal; interhuman transfer is uncommon),
and sapronoses (the source is an abiotic
substrate, nonliving environment; inter-
human transfer is exceptional). The
source of infection is often the reservoir
or, in ecologic terms, the habitat where
the etiologic agent of the disease normal-
ly thrives, grows, and replicates. A char-
acteristic feature of most zoonoses and
sapronoses is that once transmitted to
humans, the epidemic chain is usually
aborted, but the clinical course might be
sometimes quite severe, even fatal. An
ecologic rule specifies that an obligatory
parasite should not kill its host to benefit
from the adapted long-term symbiosis,
whereas an occasionally attacked alien
host, such as a human, might be subject-
ed to a severe disease or even killed rap-
idly by the parasite because no evolu-
tionary adaptation to that host exists (1).
In this letter, only microbial infections
are discussed; metazoan invasion and
infestations have been omitted.
Anthroponoses (Greek “anthrópos” =
man, “nosos” = disease) are diseases
transmissible from human to human.
Examples include rubella, smallpox,
diphtheria, gonorrhea, ringworm
(Trichophyton rubrum), and trichomoni-
asis. 
Zoonoses (Greek “zoon” = animal) are
diseases transmissible from living ani-
mals to humans (2). These diseases were
formerly called anthropozoonoses, and
the diseases transmissible from humans
to animals were called zooanthro-
ponoses. Unfortunately, many scientists
used these terms in the reverse sense or
indiscriminately, and an expert commit-
tee decided to abandon these two terms
and recommended “zoonoses” as “dis-
eases and infections which are naturally
transmitted between vertebrate animals
and man” (3). A limited number of
zoonotic agents can cause extensive out-
breaks; many zoonoses, however, attract
the public’s attention because of the high
death rate associated with the infections.
In addition, zoonoses are sometimes con-
tagious for hospital personnel (e.g., hem-
orrhagic fevers). Zoonotic diseases can
be classified according to the ecosystem
in which they circulate. The classifica-
tion is either synanthropic zoonoses,
with an urban (domestic) cycle in which
the source of infection are domestic and
synanthropic animals (e.g., urban rabies,
cat scratch disease, and zoonotic ring-
worm) or exoanthropic zoonoses, with a
sylvatic (feral and wild) cycle in natural
foci (4) outside human habitats (e.g.,
arboviroses, wildlife rabies, Lyme dis-
ease, and tularemia). However, some
zoonoses can circulate in both urban and
natural cycles (e.g., yellow fever and
Chagas disease). A number of zoonotic
agents are arthropod-borne (5); others
are transmitted by direct contact, alimen-
tary (foodborne and waterborne), or
aerogenic (airborne) routes; and some
are rodent-borne. 
Sapronoses (Greek “sapros” = decay-
ing; “sapron” means in ecology a decay-
ing organic substrate) are human dis-
eases transmissible from abiotic environ-
ment (soil, water, decaying plants, or ani-
mal corpses, excreta, and other substra-
ta). The ability of the agent to grow
saprophytically and replicate in these
substrata (i.e., not only to survive or con-
taminate them secondarily) are the most
important characteristics of a sapronotic
microbe. Sapronotic agents thus carry on
two diverse ways of life: saprophytic (in
an abiotic substrate at ambient tempera-
ture) and parasitic (pathogenic, at the
temperature of a homeotherm vertebrate
host). Typical sapronoses are visceral
mycoses caused by dimorphic fungi
(e.g., coccidioidomycosis and histoplas-
mosis), “monomorphic” fungi (e.g.,
aspergillosis and cryptococcosis), certain
superficial mycoses (Microsporum gyp-
seum), some bacterial diseases (e.g.,
legionellosis), and protozoan (e.g., pri-
mary amebic meningoencephalitis).
Intracellular parasites of animals (virus-
es, rickettsiae, and chlamydiae) cannot
be sapronotic agents. The term “saprono-
sis” was introduced in epidemiology as a
useful concept (6–8). For these diseases
the expert committee applied the term
“sapro-zoonoses,” defined as “having
both a vertebrate host and a nonanimal
developmental site or reservoir (organic
matter, soil, and plants)” (3,9). However,
the term sapronoses is more appropriate
because animals are not the source of
infection for humans. While anthro-
ponoses and zoonoses are usually the
domains for professional activities of
human and veterinary microbiologists,
respectively, sapronoses may be the
domain for environmental microbiolo-
gists. The underdiagnosis rate for
sapronoses is probably higher than that
for anthroponoses and zoonoses, and an
increase should be expected in both inci-
dence and number of sapronoses.
Legionellosis, Pontiac fever, nontubercu-
lous mycobacterioses, and primary ame-
bic meningoencephalitis are a few
sapronoses that have emerged in the past
decade. In addition, the number of
opportunistic infections in immunosup-
pressed patients has grown markedly;
many of these diseases and some nosoco-
mial infections are, in fact, also
sapronoses. 
As with any classification, grouping
human diseases in epidemiologic cate-
gories according to the source of infec-
tion has certain pitfalls. Some arthropod-
borne diseases (urban yellow fever,
dengue, epidemic typhus, tickborne
relapsing fever, epidemic relapsing fever,
and malaria) might be regarded as
anthroponoses rather than zoonoses
because the donor of the infectious blood
for the vector is an infected human and
not a vertebrate animal. However, the
human infection is caused by an (inverte-
brate) animal in which the agent repli-
cates, and the term zoonoses is preferred.
HIV is of simian origin with a sylvatic
cycling among wild primates and acci-
dental infection of humans who hunted
or ate them; the human disease (AIDS)might thus have been regarded as a
zoonosis in the very first phase but later
has spread in the human population as a
typical anthroponosis and caused the
present pandemic. Similarly, pandemic
strains of influenza developed through an
antigenic shift from avian influenza A
viruses. For some etiologic agents or
their genotypes, both animals and
humans are concurrent reservoirs (hepa-
titis virus E, Norwalk-like calicivirus,
enteropathogenic Escherichia coli,
Pneumocystis, Cryptosporidium, Giar-
dia, and  Cyclospora); these diseases
might conditionally be called anthropo-
zoonoses. Other difficulties can occur
with classifying diseases caused by
sporulating bacteria (Clostridium  and
Bacillus): Their infective spores survive
in the soil or in other substrata for very
long periods, though they are usually pro-
duced after a vegetative growth in the abi-
otic environment, which can include ani-
mal carcasses. These diseases should
therefore be called sapronoses. For some
other etiologic agents, both animals and
abiotic environment can be the reservoir
(Listeria, Erysipelothrix, Yersinia pseudo-
tuberculosis, Burkholderia pseudomallei,
and Rhodococcus equi), and the diseases
might be, in fact, called saprozoonosis
(not sensu 9 ) in that their source can be
either an animal or an abiotic substrate.
For a concise list of anthropo-, zoo-,
and sapronoses, see the online appendix
available from: URL: http://www.
cdc.gov/ncidod/EID/vol9no3/02-0208-
app.htm.
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Multidrug-Resistant
Shigella dysenteriae
Type 1: Forerunners
of a New Epidemic
Strain in Eastern
India?
To the Editor: Multidrug-resistant
Shigella dysenteriae type 1 caused an
extensive epidemic of shigellosis in east-
ern India in 1984 (1). These strains were,
however, sensitive to nalidixic acid, and
clinicians found excellent results by
using it to treat bacillary dysentery cases.
Subsequently, in 1988 in Tripura, an
eastern Indian state, a similar outbreak of
shigellosis occurred in which the isolated
strains of S. dysenteriae type 1 were even
resistant to nalidixic acid (2). Since then,
few cases of shigellosis have occurred in
this region, and S. dysenteriae type 1
strains are scarcely encountered (3). In
other regions of the world, especially in
Southeast Asia, low-level resistance to
fluoroquinolones in Shigella spp. has
been observed for some time (4,5). 
After a lapse of almost 14 years, clus-
ters of patients with acute bacillary
dysentery were seen at the subdivisional
hospital, Diamond Harbour, in eastern
India. No cases of dysentery had been
reported during the comparable period in
previous years. A total of 1,124 case-
patients were admitted from March
through June 2002. The startling feature
of these infections was their unrespon-
siveness to even the newer fluoro-
quinolones such as norfloxacin and
ciprofloxacin, the drugs often used to
treat shigellosis. Clinicians tried various
antibiotics, mostly in combinations,
without benefit. Clinicians also random-
ly used anti-amoebic drugs without suc-
cess. 
An investigating team collected nine
fresh fecal samples from dysentery
patients admitted to this hospital; 4
(44%) yielded S. dysenteriae type 1 on
culture. For isolation of Shigella spp.,
stool samples were inoculated into
MacConkey agar and Hektoen Enteric
agar (Difco, Detroit, MI), and the charac-
teristic colonies were identified by stan-
dard biochemical methods (6).
Subsequently, serogroups and serotypes
were determined by visual inspection of
slide agglutination tests with commercial
antisera (Denka Seiken, Tokyo).
Antimicrobial susceptibility testing was
performed by an agar diffusion disk
method, as recommended by the
National Committee for Clinical
Laboratory Standards (7). Results
showed that the organisms were resistant
to all commonly used antibiotics, includ-
ing the fluoroquinolones (norfloxacin
and ciprofloxacin) but were sensitive to
ofloxacin. On our advice, the clinicians
used ofloxacin with good results.
A similar outbreak of S. dysenteriae
type 1 occurred in the northern part of
West Bengal in eastern India among tea
garden laborers from April 2002 to May
2002; 1,728 persons were affected
(attack rate of 25.6%). Sixteen persons
died. The isolated S. dysenteriae type 1
strains were found intermediately sensi-
LETTERS
404 Emerging Infectious Diseases • Vol. 9, No. 3, March 2003